BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18640245)

  • 1. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Feng HL; Leng Y; Ma CH; Zhang J; Ren M; Chuang DM
    Neuroscience; 2008 Aug; 155(3):567-72. PubMed ID: 18640245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch pathway is activated in cell culture and mouse models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of neuroprotection for lithium and valproate.
    Wang SY; Ren M; Jiang HZ; Wang J; Jiang HQ; Yin X; Qi Y; Wang XD; Dong GT; Wang TH; Yang YQ; Feng HL
    Neuroscience; 2015 Aug; 301():276-88. PubMed ID: 26067594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
    Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
    J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid.
    Jiang HZ; Wang SY; Yin X; Jiang HQ; Wang XD; Wang J; Wang TH; Qi Y; Yang YQ; Wang Y; Zhang CT; Feng HL
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats.
    Sharma S; Taliyan R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Mar; 388(3):337-49. PubMed ID: 25547373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice.
    Ahn SW; Kim JE; Park KS; Choi WJ; Hong YH; Kim SM; Kim SH; Lee KW; Sung JJ
    J Neurol Sci; 2012 Sep; 320(1-2):1-5. PubMed ID: 22698482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of valproic acid in suppressing disease progression of ALS model mice.
    Sugai F; Yamamoto Y; Miyaguchi K; Zhou Z; Sumi H; Hamasaki T; Goto M; Sakoda S
    Eur J Neurosci; 2004 Dec; 20(11):3179-83. PubMed ID: 15579172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury.
    Yu F; Wang Z; Tanaka M; Chiu CT; Leeds P; Zhang Y; Chuang DM
    J Neurosurg; 2013 Sep; 119(3):766-73. PubMed ID: 23848820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
    Kim J; Kim TY; Cho KS; Kim HN; Koh JY
    Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.
    Leng Y; Wang Z; Tsai LK; Leeds P; Fessler EB; Wang J; Chuang DM
    Mol Psychiatry; 2015 Feb; 20(2):215-23. PubMed ID: 24468826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis.
    Gyawali A; Latif S; Choi SH; Hyeon SJ; Ryu H; Kang YS
    J Biomed Sci; 2022 Jan; 29(1):2. PubMed ID: 35012534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS.
    Koh SH; Kim Y; Kim HY; Hwang S; Lee CH; Kim SH
    Exp Neurol; 2007 Jun; 205(2):336-46. PubMed ID: 17433298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Zhao Z; Fu J; Li S; Li Z
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis.
    Teng YD; Choi H; Huang W; Onario RC; Frontera WR; Snyder EY; Sabharwal S
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):155-8. PubMed ID: 16388902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Kiaei M; Petri S; Kipiani K; Gardian G; Choi DK; Chen J; Calingasan NY; Schafer P; Muller GW; Stewart C; Hensley K; Beal MF
    J Neurosci; 2006 Mar; 26(9):2467-73. PubMed ID: 16510725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.
    Chiu CT; Liu G; Leeds P; Chuang DM
    Neuropsychopharmacology; 2011 Nov; 36(12):2406-21. PubMed ID: 21796107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.